Dermabond Treatment for Gastric Variceal Bleeding
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology, Gastrointestinal |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/17/2018 |
| Start Date: | December 2012 |
| End Date: | December 2020 |
| Contact: | John M, DeWitt, MD |
| Email: | jodewitt@iu.edu |
| Phone: | 317-944-0880 |
Endoscopic Ultrasound (EUS) Gastric Variceal Bleeding Database Repository
The purpose of having a database is to collect data related to endoscopic ultrasound
procedures performed by Indiana University EUS physicians; specifically, for the treatment of
gastric variceal bleeding This data will be used for research purposes only to determine the
clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding. The
physicians will also be able to better understand the patient's condition and disease process
that may lead to improved standard of care and improved patient management.
procedures performed by Indiana University EUS physicians; specifically, for the treatment of
gastric variceal bleeding This data will be used for research purposes only to determine the
clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding. The
physicians will also be able to better understand the patient's condition and disease process
that may lead to improved standard of care and improved patient management.
Clinical outcomes research is one of the strengths of the EUS group. As a group, the
physicians need a tracking system for specific treatment modalities, and data to determine
the impact of endoscopic ultrasound for patients with gastric variceal bleeding. Gastric
variceal bleeding is a severe complication of portal hypertension with significant morbidity
and mortality with limited therapeutic options. Currently, there is no database in existence
for endoscopic ultrasound clinical research for specific procedures. Also, there is limited
data regarding the outcome of endoscopic sclerotherapy with cyanoacrylate in the United
States.
physicians need a tracking system for specific treatment modalities, and data to determine
the impact of endoscopic ultrasound for patients with gastric variceal bleeding. Gastric
variceal bleeding is a severe complication of portal hypertension with significant morbidity
and mortality with limited therapeutic options. Currently, there is no database in existence
for endoscopic ultrasound clinical research for specific procedures. Also, there is limited
data regarding the outcome of endoscopic sclerotherapy with cyanoacrylate in the United
States.
Inclusion Criteria:
Anyone receiving treatment with DermaBond for treatment gastric varices.
Exclusion Criteria:
No evidence of gastric varices.
We found this trial at
1
site
550 University Boulevard
Indianapolis, Indiana 46202
Indianapolis, Indiana 46202
Principal Investigator: John M. DeWitt, MD
Click here to add this to my saved trials
